[15] [13] Other notable adverse effects include: Hypoglycemia : Low risk when used as monotherapy, but increased when combined with insulin or sulfonylureas Injection site reactions : Erythema, pruritus, or discomfort in approximately 2% to 4% of patients Fatigue and dizziness : Reported in 5% to 8% of participants Increased heart rate : Mean increases of 2 to 4 beats per minute observed [1] [2] Serious adverse events were uncommon but included acute pancreatitis (approximately 0.2% incidence), gallbladder disease including cholecystitis and cholelithiasis (0.6% in diabetes trials and up to 2.5% in weight management trials, associated with rapid weight loss), and acute kidney injury, typically in the context of severe dehydration from gastrointestinal symptoms
Ultimately, the question isn't just "how much is it?" The better question is, "what is sustainable health and a transformed life worth to me?" The cost is a number
For people with type-2 diabetes, GLP-1 medications may begin lowering blood sugar within days or weeks after starting treatment
Potential In Vitro Research Applications Research Summary GHK-Cu demonstrates quite a bit of potential for laboratory research applications across multiple areas of study
Some of the metabolites, such as 16-OHE 1, are also able to activate the estrogen receptors
WARNING: Cancer and Reproductive Harm - www